PRO.MED.CS Baltic - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 490,916 | 405,967 | 321,665 | 297,010 | 335,854 | 511,585 | 593,259 | 683,501 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 9,160 | 8,626 | 7,654 | 8,247 | 8,151 | 14,549 | 14,879 | 18,072 |
| Equity | 24,329 | 32,955 | 40,609 | 48,856 | 57,007 | 71,556 | 86,435 | 104,507 |
| Liabilities | 45,424 | 31,270 | 37,801 | 42,311 | 44,699 | 59,930 | 57,291 | 19,038 |
| Non-current assets | 1,632 | 962 | 412 | 1,045 | 1,080 | 921 | 3,091 | 2,129 |
| Current assets | 69,156 | 63,263 | 78,214 | 90,429 | 100,796 | 129,187 | 141,624 | 122,317 |
| Total assets | 70,788 | 64,225 | 78,626 | 91,474 | 101,876 | 130,108 | 144,715 | 124,446 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 39,266 | 38,824 | 37,513 |
| Social insurance contributions | - | - | - | - | - | 42,336 | 21,797 | 48,999 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -4.5% | -17.3% | -20.8% | -7.7% | +13.1% | +52.3% | +16.0% | +15.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 12.9% | 13.4% | 9.7% | 9.0% | 8.0% | 11.2% | 10.3% | 14.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 37.7% | 26.2% | 18.8% | 16.9% | 14.3% | 20.3% | 17.2% | 17.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.9% | 2.1% | 2.4% | 2.8% | 2.4% | 2.8% | 2.5% | 2.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.9 | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 101,570 | 93,685 | 107,222 | 114,973 | 143,939 | 139,522 | 173,635 | 182,267 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
PRO.MED.CS Baltic - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-11-18 | 2025-11-27 | 0.01 |
| 2025-10-23 | 2025-10-29 | 0.01 |
| 2025-07-16 | 2025-07-16 | 19.63 |
| 2024-11-18 | 2024-11-20 | 0.05 |
| 2024-10-24 | 2024-10-30 | 0.05 |
| 2024-08-19 | 2024-08-20 | 0.17 |
| 2024-07-24 | 2024-07-30 | 0.17 |
| 2024-07-16 | 2024-07-17 | 51.89 |
| 2024-06-18 | 2024-06-27 | 51.89 |
| 2023-10-25 | 2023-10-25 | 10.86 |
| 2022-07-25 | 2022-07-28 | 0.16 |
PRO.MED.CS Baltic - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
PRO.MED.CS Baltic, UAB (code 303012256) is a private limited liability company operating in market research and public opinion polling. In 2025, the latest financial year, the company generated revenue of €683.5K, up 15.2% year on year and 33.6% over two years. Net profit increased to €18.1K, compared with €14.9K in 2024 and €14.5K in 2023, while the profit margin remained stable at 2.6% in 2025 after 2.5% in 2024 and 2.8% in 2023. The balance sheet shows total assets of €124.4K, equity of €104.5K and liabilities of €19.0K at year-end 2025. Equity represented 84.0% of assets, and the debt-to-equity ratio stood at 0.18, indicating a conservative financial structure. Asset turnover was 5.49x, ROE reached 17.3% and ROA 14.5% in 2025. Revenue per employee was €227.8K, with profit per employee of €6.0K, suggesting solid productivity alongside moderate profitability.